Cargando…
A randomized, double-blind, placebo-controlled, multicenter clinical trial for efficacy and safety of traditional Chinese medicine combined with antibiotics in the treatment of bacterial pneumonia in children
BACKGROUND: Pneumonia is the second leading cause of death in children worldwide after preterm birth and certification. Bacteria, viruses, mycoplasma, and other microorganisms are known to be the main causes of pneumonia, of which bacterial pathogenic factors account for 12.5% of cases. The inventio...
Autores principales: | Wei, Lina, Guo, Yina, Fei, Yutong, Luo, Lin, Wang, Caiwen, Wang, Xuejiao, Sun, Haihang, Liu, Liang, Han, Jing, Ren, Xiaoting, Yao, Bo, Wang, Lei, Wang, Yijie, Sun, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738059/ https://www.ncbi.nlm.nih.gov/pubmed/33327240 http://dx.doi.org/10.1097/MD.0000000000023217 |
Ejemplares similares
-
Comparative efficacy and safety of traditional Chinese patent medicine in the treatment of Mycoplasma pneumoniae pneumonia in children: A protocol for systematic review and meta-analysis
por: He, Hongan, et al.
Publicado: (2020) -
Association between parental occupational exposure and the risk of asthma in offspring: A meta-analysis and systematic review
por: Ren, Xiaoting, et al.
Publicado: (2023) -
Efficacy and safety of Tuina for treatment of pediatric recurrent respiratory tract infections: A protocol for systematic review and meta-analysis
por: Tian, Ye, et al.
Publicado: (2021) -
Evaluation on blood coagulation and C-reactive protein level among children with mycoplasma pneumoniae pneumonia by different chest imaging findings
por: Wang, Juan, et al.
Publicado: (2021) -
Impact of Epstein-Barr virus coinfection in Mycoplasma pneumoniae pneumonia
por: Xu, Yingchun, et al.
Publicado: (2020)